ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,001.53
      -0.52%
      US Tech 100
      21,242.80
      -0.60%
      Dow Jones
      42,339.94
      -0.41%
      Brent Oil
      74.795
      4.23%
      Bitcoin
      103,758.99
      -2.81%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Atossa Therapeutics Inc (ATOS) Quote

      Atossa Therapeutics Inc

      Atossa Therapeutics Inc (ATOS)

      NASDAQ
      0.8291
      -0.022
      ( -2.58% )
      Updated: 13:04:49
      15 min delayed - Upgrade to Realtime

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.8291
      Bid
      0.8283
      Ask
      0.8299
      Volume
      228,704
      0.82 Day's Range 0.851
      0.5526 52 Week Range 1.66
      Market Cap
      107.095M
      Previous Close
      0.8511
      Open
      0.85
      Last Trade
      13
      @
      0.8291
      Last Trade Time
      13:07:46
      Financial Volume
      $ 190,963
      VWAP
      0.834977
      Average Volume (3m)
      695,522
      Shares Outstanding
      129,170,004
      Dividend Yield
      -
      PE Ratio
      -4.20
      Earnings Per Share (EPS)
      -0.2
      Revenue
      -
      Net Profit
      -25.5M

      About Atossa Therapeutics Inc

      Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.atossatherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Atossa Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATOS. The last closing price for Atossa Therapeutics was $0.85. Over the last year, Atossa Therapeutics shares have traded in a share price range of $ 0.5526 to $ 1.66.

      Atossa Therapeutics currently has 129,170,004 shares outstanding. The market capitalization of Atossa Therapeutics is $109.94 million. Atossa Therapeutics has a price to earnings ratio (PE ratio) of -4.20.

      Ask ADVFN Intelligence (AI)

      ATOS Latest News

      More News

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 13 2025
      ATOS (-2.58%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 13 2025
      ATOS (-2.58%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0809-8.890109890110.910.9340.81046771960.86503743CS
      4-0.1509-15.39795918370.9810.73026654300.8530192CS
      120.05917.675324675320.771.070.55266955220.79116535CS
      26-0.2419-22.58636788051.0711.080.55266969410.8304217CS
      52-0.3309-28.5258620691.161.660.55267637511.08580683CS
      156-0.1809-17.91089108911.012.310.57656231.13311225CS
      260-2.2109-72.72697368423.049.80.536199293.10343536CS

      ATOS - Frequently Asked Questions (FAQ)

      What is the current Atossa Therapeutics share price?
      The current share price of Atossa Therapeutics is $ 0.8291
      How many Atossa Therapeutics shares are in issue?
      Atossa Therapeutics has 129,170,004 shares in issue
      What is the market cap of Atossa Therapeutics?
      The market capitalisation of Atossa Therapeutics is USD 109.94M
      What is the 1 year trading range for Atossa Therapeutics share price?
      Atossa Therapeutics has traded in the range of $ 0.5526 to $ 1.66 during the past year
      What is the PE ratio of Atossa Therapeutics?
      The price to earnings ratio of Atossa Therapeutics is -4.2
      What is the reporting currency for Atossa Therapeutics?
      Atossa Therapeutics reports financial results in USD
      What is the latest annual profit for Atossa Therapeutics?
      The latest annual profit of Atossa Therapeutics is USD -25.5M
      What is the registered address of Atossa Therapeutics?
      The registered address for Atossa Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Atossa Therapeutics website address?
      The website address for Atossa Therapeutics is www.atossatherapeutics.com
      Which industry sector does Atossa Therapeutics operate in?
      Atossa Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CEROCERo Therapeutics Holdings Inc
      $ 20.584
      (199.71%)
      		46.8M
      RBNERobin Energy Ltd
      $ 12.85
      (132.79%)
      		33.88M
      ACXPAcurx Pharmaceuticals Inc
      $ 0.6651
      (116.57%)
      		288.71M
      VERVVerve Therapeutics Inc
      $ 11.215
      (78.87%)
      		71.05M
      EYENEyenovia Inc
      $ 4.95
      (66.67%)
      		10.24M
      SDSTStardust Power Inc
      $ 0.184
      (-52.61%)
      		32.37M
      SHOTWSafety Shot Inc
      $ 0.015
      (-49.66%)
      		5.65k
      RUNSunrun Inc
      $ 5.805
      (-39.78%)
      		87.28M
      SEDGSolarEdge Technologies Inc
      $ 15.7901
      (-34.15%)
      		26.26M
      ADILAdial Pharmaceuticals Inc
      $ 0.2346
      (-27.84%)
      		5.37M
      PCSAProcessa Pharmaceuticals Inc
      $ 0.2423
      (7.64%)
      		507.68M
      ACXPAcurx Pharmaceuticals Inc
      $ 0.6651
      (116.57%)
      		288.71M
      GNLNGreenlane Holdings Inc
      $ 0.0107
      (-13.71%)
      		269.41M
      HCTIHealthcare Triangle Inc
      $ 0.0224
      (-15.15%)
      		216.66M
      LCIDLucid Group Inc
      $ 2.16
      (0.47%)
      		109.04M

      ATOS Discussion

      View Posts
      eb0783 eb0783 5 months ago
      Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025.

      https://investors.atossatherapeutics.com/news-releases/news-release-details/atossa-therapeutics-issues-letter-shareholders-highlighting-2024
      👍️0
      glenn1919 glenn1919 5 months ago
      ATOS.........................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      XenaLives XenaLives 10 months ago
      Why on earth did it take me so long to find this?



      Following...

      https://x.com/stevenquay
      👍️0
      XenaLives XenaLives 10 months ago
      I think I'm in love... LOL!!!



      Historical perspective:

      👍️0
      XenaLives XenaLives 10 months ago
      More interesting...

      https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      XenaLives XenaLives 10 months ago
      ATOS chart...

      👍️0
      XenaLives XenaLives 10 months ago
      Interesting .. also from Google...

      A response to this query...

      what is unique about atossa therapeutics inc

      Response...

      Is Atossa Therapeutics a good buy?
      Why is Atossa stock dropping?
      Who owns Atossa Therapeutics?
      What is the target price for Atossa Genetics?
      Stock Price Target ATOS
      High $6.25
      Median $6.00
      Low $4.00
      Average $5.42
      Current Price $1.39

      ATOS | Atossa Therapeutics Inc. Analyst Estimates & Rating - WSJ

      WSJ
      https://www.wsj.com › quotes › ATOS › research-ratings
      Search for: What is the target price for Atossa Genetics?
      What is the stock price forecast for Atossa Therapeutics in 2025?
      What does Atossa Therapeutics do?


      👍️0
      XenaLives XenaLives 10 months ago
      From Google Generative AI:


      Atossa Therapeutics is a clinical-stage biopharmaceutical company that develops innovative medicines for oncology, with a focus on breast cancer and other breast conditions. Some unique aspects of Atossa Therapeutics include:
      Patented (Z)-endoxifen
      Atossa has patented the chemical process and composition of matter for (Z)-endoxifen, as well as a patented oral enteric capsule formulation.
      Phase 2 I-SPY 2 Clinical Trial
      Atossa is fully enrolling this trial, which is evaluating (Z)-endoxifen as a neoadjuvant treatment for patients with newly diagnosed estrogen receptor-positive breast cancer.
      Phase 2 trials
      Atossa is currently studying (Z)-endoxifen in four Phase 2 trials, including one in healthy women with measurable breast density, one in women diagnosed with ductal carcinoma in situ, and two other studies.
      U.S. patents
      Atossa's (Z)-endoxifen is protected by three issued U.S. patents and numerous pending patent applications.
      👍️0
      XenaLives XenaLives 10 months ago
      Intriguing science...
      👍️0
      XenaLives XenaLives 10 months ago

      (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

      https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-00701&r=1
      👍️0
      XenaLives XenaLives 10 months ago
      Link to Atossa pipeline...
      https://atossatherapeutics.com/product-pipeline/
      👍️0
      XenaLives XenaLives 10 months ago
      Following - some valid science is going on here...
      👍️0
      glenn1919 glenn1919 10 months ago
      ATOS....................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 11 months ago
      ATOS.........................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 12 months ago
      ATOS...............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️ 1
      Joeyohso Joeyohso 1 year ago
      Also no debt and 90m+ in cash. That is unheard of for a research pharma company. They also are extending the employee stock purchase program for all of 2024. This stock is a gem
      👍️0
      ShadowDiviner72 ShadowDiviner72 1 year ago
      New PR, and data release shows that Endoxifen does not only stop the tumor from growing...

      It even shows that it eliminates the tumor !!!!!! They cured a patient from breast cancer by taking a simple pill during 6 months!

      INCREDIBLE
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS...........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Joeyohso Joeyohso 1 year ago
      Why the dump today? I was able to grab some at 1.65
      👍️0
      Monksdream Monksdream 1 year ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 1 year ago
      ATOS new 52 hi
      👍️0
      Monksdream Monksdream 1 year ago
      ATOS 10Q due 4/5
      👍️0
      Monksdream Monksdream 1 year ago
      ATOS new 52 hi
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      ATOS..LEVEL 2 LOOKING VERY NICE IN PRE
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      ATOS...GET READY TO RUMBLE...WE ARE LOCKED IN AND LOADED TO 1.73
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS.............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS.........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 years ago
      ATOS................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Birdbrain Ideas Birdbrain Ideas 2 years ago
      There hasn't been a post on this board in six weeks. If these Stage 2 trials turn out well, this board will light up along with the share price.
      👍️0
      Laster Laster 2 years ago
      I loved that wall at $1.04 yesterday. It was calling my name. I was too slow.
      Then it was taken out. I wasn’t too upset because….
      I was lucky enough for another wall at $1.05 that I helped take out. Then boom.
      Chart looked good. News good. Repurchase plan news excellent.
      What’s not to like.
      Hope to see if move back above $2.
      Good luck.
      👍️0
      tw0122 tw0122 2 years ago
      Looking good. Hidden gem not any longer
      👍️0
      killrEngineer killrEngineer 2 years ago
      Wow. No comments?
      10 million share repurchase announcement yesterday and study enrollment announcement today.
      👍️0
      DrJinx DrJinx 3 years ago
      This aged like milk. How's that priming for a big run up working out for you? Maybe someday people will realize the company is smoke and mirrors. Keep in mind your CEO is old as F, he dies... this thing tanks even harder.
      👍️0
      Engle1488 Engle1488 3 years ago
      We are primed for a big run up people. In at 1.04
      👍️0
      Agreed Agreed 3 years ago
      The market cap is less than their holdings in cash...clearly undervalued.
      👍️0
      Agreed Agreed 3 years ago
      Insider buying by CEO and CFO, new patent protections...looking promising.
      👍️0
      DollarSquad DollarSquad 3 years ago
      Yes. You likely lost a lot of money. This investment is worthless. RMSL
      👍️0
      4MVault 4MVault 4 years ago
      Did something just happen?
      👍️0
      slugo1 slugo1 4 years ago
      Looking for bottom here
      👍️0
      ttottip ttottip 4 years ago
      Yes, very soon. This will reverse the trend.
      👍️0
      slugo1 slugo1 4 years ago
      Soon
      👍️0
      ttottip ttottip 4 years ago
      Soon the 2.5's , 2.6's .....
      👍️0
      slugo1 slugo1 4 years ago
      Yes
      👍️0
      ttottip ttottip 4 years ago
      The 2.6's on the horizon.
      👍️0
      slugo1 slugo1 4 years ago
      That's one of the things I like about them Also there should be some updates coming
      👍️0
      ttottip ttottip 4 years ago
      140 millions of dollars cash? ATOS can do great things with this money.
      👍️0
      slugo1 slugo1 4 years ago
      Nice buy worth alot when this hits $10.00
      👍️0

      Your Recent History

      NASDAQ
      ATOS
      Atossa Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads